PRTS vs TSLA

PRTS exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a high probability of continued financial deterioration. While the stock trades at a very low Price/Sales multiple (0.12), this is offset by negative profit margins, declining year-over-year revenue (-9.80%), and a catastrophic 5-year price decline of 94.5%. Recent short-term price gains appear speculative and are not supported by the underlying operational health or the poor Quick Ratio (0.41), which suggests significant liquidity risk tied to inventory.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.